Carving a niche for immunotherapy in ovarian cancer

Oncotarget. 2021 Jan 5;12(1):4-7. doi: 10.18632/oncotarget.27864.
No abstract available

Keywords: PARP inhibitor; combination therapy; immunotherapy; ovarian cancer.

Publication types

  • Editorial